ArticleFrontiers in endocrinology2026
Machine learning-based ultrasound radiomics for prediction of 6-month local thermal ablation response in benign thyroid nodules: a multicenter study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to develop a machine learning (ML)-based ultrasound (US) radiomics model for prediction of 6-month local treatment response (LTR) ofthermal ablation (TA) for benign thyroid nodules (BTNs). Methods: Between January 2018 and July 2021, a total of 388 patients who underwent US-guided TA in three centers were included. US radiomics features were extracted from preoperative grayscale US images and data dimensionality reduced using principal component analysis and least absolute shrinkage and selection operator. Then, support vector machine (SVM), logistic regression, a decision tree, K-nearest neighbors, and random forest were applied to selected key US radiomics features for distinguishing a volume reduction ratio (VRR) ≥50% or <50%. Factors affecting 6-month LTR were assessed using multivariate logistic regression to construct a clinical model. Receiver operating characteristic curves were plotted to compare the predictive performance between radiomics-based ML and clinical models. Results: At 6 months post-ablation, patients with VRR ≥ 50% were 75.8% (292/372) in the training and internal test cohorts and 59.4% (19/32) in the external test cohort. Finally, 10 US radiomics features were selected for analysis. Solidity was the only independent clinical predictor associated with VRR<50%. Among the five algorithms, the SVM model achieved the optimal predictive efficacy, with an area under the curve (AUC) = 0.81 in the internal test set. The AUC of the SVM-based US radiomics model was significantly higher than that of the clinical model in both internal (0.81 vs. 0.63, P< 0.05) and external test cohorts (0.77 vs. 0.54, P< 0.05). Conclusion: The SVM-based US radiomicsmodel yielded a satisfactory performance for predicting the 6-month LTR, outperforming the clinical model, and facilitating decision-making in favor of TA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.